Biochemical markers for diagnosis of diseases and follow up

Slides:



Advertisements
Similar presentations
Biochemical Markers for Diagnosis of Myocardial Infarction.
Advertisements

Dr. Gehan Mohamed Dr. Abdelaty Shawky
1 Lecture | Dr. Usman Ghani
Liver Function Tests (LFTs)
1 CLINICAL CHEMISTRY-2 (MLT 302) LIVER FUNCTION AND THE BILIARY TRACT LECTURE FOUR Dr. Essam H. Aljiffri.
Enzymes in Body Fluids Lecture outline
Lecture 4. Special chemistry Definition Special Chemistry is a subsection of the Chemistry Laboratory of the Division of Clinical Pathology. This includes.
(clinical biochemistry of enzymes)
CMP LABS By Tiffany Potter. COMPLETE METABOLIC PANEL CMP includes BMP NA ( mEq/L CL ( mmol/L) K ( mEq/L) GLU ( mg/dL) BUN (7-20.
Enzymes in Clinical Diagnosis
Enzymes Dr. Noha Soliman.
Alanine Transaminase.
Liver function tests Lecture 3.
Eleni Galani Medical Oncologist
بسم الله الرحمن الرحيم.
Biochemical Markers of Myocardial Infarction
Tumor markers Present; by Dr. Andalib Isfahan Medical School
Liver Function Tests. Tests Based on Detoxification and Excretory Functions.
Biochemical markers in disease diagnosis
Enzymes Biochemistry (BMS) L.Noha Soliman.
Blood Studies Liver function test (LFT) Group of biochemical tests Group of biochemical tests Uses of liver function test (LFTs) Differential diagnosis.
Enzyme Clinical Application
Biochemical Investigations In Heart Disaeses
Biochemical markers for diagnosis of diseases and follow up Dr. Rana Hasanato Associate professor and consultant Head of clinical chemistry department.
CLINICAL ENZYMOLOGY. Measurements of the activity of enzymes in plasma are of value in the diagnosis and management of a wide variety of diseases.
Pancreas. Pancreatic Enzymes Applications: Acute pancreatitis Obstruction of the pancreatic duct Amylase: Rapid riseSerum: Urine:Persists longer Lipase:
By: Liam Higgins and Cole Bardawill. The Pancreas  The pancreas secretes insulin in response to glucose levels in the blood.  Pancreatic fluid also.
Biochemical markers for diagnosis and follow up of disease
Biochemical Markers of Myocardial Infarction
1 Enzymes Dr. Tagreed Osman. An enzyme is a protein catalyst that accelerates the speed of a chemical reaction by binding specifically to a substrate,
Welcome Advanced Clinical Chemistry BISC Dr Atef Masad PhD Biomedicine Uinited Kingdom Advanced Clinical Chemistry BISC 6360.
Biochemical Markers for Diagnosis of Myocardial Infarction
Lab 3 ALT and AST Daheeya AlEnazi.
Liver function Tests What are liver tests? Liver tests (LTs) are blood tests used to assess the general state of the liver or biliary system. Few of these.
Lab # 2 Liver Function Tests (LFTs) ALT&AST T.A. Bahiya M. Osrah.
Khadija Balubaid KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab (BIOC 416) 2013 Liver Function profile (LFT) Enzymes.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Determination of plasma enzymes
CLINICAL APPLICATION OF UREA MEASUREMENTS METABOLIC ASPECTS OF KIDNEY METABOLISM.
Biomarkers of ovarian cancer and cysts Reproductive Block 1 Lecture Dr. Usman Ghani.
Clinical usage of enzymes
Common pitfall in Oncology Luangyot Thongthieang, MD MEDICAL ONCOLOGY UNIT INTERNAL MEDICINE, KHONKAEN HOSPITAL.
Pancreas Function testing Function testing seeks to determine whether or not the pancreas is working normally. The three functions of the pancreas are.
How Is Chemotherapy Used to Treat Cancer?
LIVER FUNCTION TESTS
Liver Function Tests (LFTs)
SURGICAL ONCOLOGY AND TUMOR MARKERS
Liver Function Tests (LFTs)
Enzymes in the Diagnosis of Pathology
Biochemical Investigations In Heart Disaeses
Biochemical Markers of Myocardial Infarction
Biochemistry MI Biomarkers Important. Extra Information.
– Color Index: Important. Extra Information. Doctors slides.
Biochemical Markers of Myocardial Infarction
Estimation of AST and ALT activity
Muthana Al-Shemeri Lab. Assistants, Mr Jamal Abdulfattah Mrs Ferdws
Interpretation Of LAB Data
biochemical markers for diagnosis and follow up of diseases
Tumor Marker Tests.
Presented By: Sally Saad Mandour Esawy
Cardiac enzymes and cardiac proteins
Determination of the enzyme ALT (SGPT) & AST activity in serum by enzymatic method using Biophotometer.
Daheeya AlEnazi Cromatest Kit
Determination of plasma enzymes
Gastroenterology & Nutrition Block Biochemistry Department
Bilirubin & Amylase Lab. 10.
Lactic Acidosis Cardiovascular Block.
Biochemical Markers of Myocardial Infarction
Biochemical markers for diagnosis of diseases and follow up
Determination of plasma enzymes
Presentation transcript:

Biochemical markers for diagnosis of diseases and follow up Foundation Block Dr. Usman Ghani

Lecture objectives Upon completion of this lecture, the students should be able to: Comprehend the importance and diagnostic qualities of various biomarkers Understand the importance of different biomarkers in the diagnosis, treatment and follow up of a disease. Recognize the types of biomarkers and their use in specific diseases such as heart, cancer, liver, kidney and pancreatic diseases.

Overview What is a biomarker? Diagnosis and prognosis Plasma and tissue-specific biomarkers Factors affecting serum biomarker levels Qualities of a good biomarker Types: Enzymes, proteins, hormones Enzymes: Amylase, lipase, trypsinogen, ALT, AST Proteins: Cystatin C, BNP, a-fetoprotein, PSA Hormones: Anti-Mullerian hormone

What is a biomarker? A biological molecule found in blood, other body fluids, or tissues that indicates a normal or abnormal process such as a disease or a condition A biomarker is measured to follow up a disease or treatment

diagnosis and prognosis Identification of a disease from its signs and symptoms Prognosis: The future outcome of a disease

Most common body fluids for measurement of biomarkers are: Serum Plasma Urine Some biomarkers are either: Plasma-specific or Tissue-specific

Plasma-specific biomarkers Normally present in plasma Perform their functions in blood High level of activity in plasma than in tissue cells Examples: blood clotting enzymes (thrombin), cholinesterase, etc.

Tissue-specific biomarkers Present inside the cell Conc. is lower in plasma Released into the body fluids in high conc. due to: cell damage defective cell membrane

Intracellular enzymes are present only in their cells of origin Some are secretory enzymes that are secreted by salivary glands, gastric mucosa and pancreas In disease, plasma levels of secretory enzymes increase when their cells are damaged The diagnosis of organ disease is done by measurement of enzymes of that tissue

Factors affecting serum biomarker levels Cell damage Rate of biomarker synthesis and clearance Enzyme inhibitors Glucose deficiency Localized hypoxia (less oxygen) Ischemia (obstruction of blood vessels) Necrosis Tissue infarction due to ischemic necrosis Myocardial infarction

Qualities of a good biomarker A good biomarker should be: Able to accurately diagnose a disease Able to accurately predict prognosis of a disease Compliant with treatment follow up Easily obtainable from blood, urine, etc.

Qualities of a good biomarker assay A good biomarker assay should be rapid to deliver results faster Sensitive Ability of an assay to detect small quantities of a marker Specific Ability of an assay to detect only the marker of interest

Types of biomarkers Enzymes Hormones Proteins

Enzymes as biomarkers Enzymes are clinically used for the diagnosis and prognosis of various diseases Examples include: Amylase, Lipase Alanine aminotransferase (ALT) Aspartate aminotransferase (AST)

Amylase and Lipase Acute pancreatitis is the inflammation of pancreas caused by: Obstruction of the pancreatic duct Gallstones Alcohol abuse Abnormal release and premature activation of pancreatic enzymes (for example amylase, lipase) Diagnosis conducted by measuring pancreatic enzymes

Amylase appears in the serum within 2-12 hours after abdominal pain Elevated serum amylase level is a diagnostic indicator of acute pancreatitis Amylase level greater than 10 times the upper limit indicates acute pancreatitis The test has low specificity because elevated serum amylase level is also present in other diseases Amylase appears in the serum within 2-12 hours after abdominal pain Free amylase (unbound form) is rapidly cleared by the kidneys

Lipase Serum lipase has higher specificity than serum amylase It appears in plasma within 4-8 hours and remains for 8-14 days Measurement of amylase and lipase give 90-95% accuracy in the diagnosis of acute pancreatitis and abdominal pain

High serum ALT and AST levels in liver diseases are due to: Alcohol abuse Medication Chronic hepatitis B and C Steatosis and steatohepatitis Autoimmune hepatitis Wilson’s disease a1-antitrypsin deficiency Malignancy Poisons and infectious agents

Alanine aminotransferase (ALT) Mostly present in liver Small amounts in heart More specific for liver disease than AST Major diagnosis: liver disease

Aspartate aminotransferase (AST) Widely distributed in heart, liver, skeletal muscle, kidney Small amounts in erythrocytes High serum activity of AST found in: Liver disease, heart disease, skeletal muscle disease, hemolysis Major diagnosis: liver and muscle diseases

Serum enzymes used in the assessment of liver function: Markers used in hepatocellular necrosis Alanine aminotransferases Aspartate aminotransferases

Proteins as biomarkers Cystatin C B-type natriuretic peptide (BNP) Tumor markers a-Fetoprotein Prostate Specific Antigen (PSA)

Cystatin C A cysteine protease inhibitor mainly produced by all nucleated cells of the body Useful biomarker for measuring glomerular filtration rate (GFR) in assessing kidney function and failure Unlike creatinine, its serum conc. is independent of gender, age or muscle mass Abnormally high serum levels of cystatin C indicates kidney failure Clinically useful marker for detecting: early kidney disease, monitoring kidney transplantation and acute kidney injury

B-type natriuretic peptide (BNP) A peptide secreted mainly in the cardiac ventricles in response to cardiac expansion and pressure overload High serum levels are observed in congestive heart failure In some pulmonary diseases, BNP levels are high but not as high as in heart failure BNP helps differentiate between pulmonary disease and heart failure An important marker for the diagnosis and prognosis of congestive heart failure Currently being investigated as a screening biomarker for heart disease

Tumor markers A molecule secreted by a tumor that is measured for diagnosis and management of a tumor a-fetoprotein Prostate specific antigen (PSA)

a-Fetoprotein In newborn babies a-fetoprotein levels are very low High conc. are observed in: Hepatocellular carcinomas (hepatoma) Testicular carcinomas GI tract carcinomas However, high serum levels are also found in benign (non-cancerous) conditions e.g. hepatitis High conc. are not always suggestive of a tumor

Prostate Specific Antigen (PSA) A serine protease enzyme also called kallikrein III, seminin Produced by prostate gland Liquefies ejaculate High serum PSA levels are observed in prostate cancer Less specific in diagnosis High serum levels are also observed in benign prostatic hypertrophy (enlarged prostate gland)

Hormones as biomarkers Anti-Mullerian hormone (AMH) A polypeptide hormone involved in sexual differentiation of male embryo In females it is produced by ovaries Prevents premature depletion of ovarian follicles Appears to be a best marker for estimating egg cell reserve in the ovaries Only growing follicles produce AMH Plasma AMH levels strongly correlate with number of growing follicles Helps assess female fertility

Take-home messages Biomarkers are used for diagnosis, prognosis and follow up of diseases A biomarker should exhibit good diagnostic and prognostic values Examples of biomarkers used in different disease will help understand their qualities and limitations

References What are biomarkers? Kyle Strimbu and Jorge A. Tavel, Curr Opin HIV AIDS. 2010 November ; 5 (6): 463–466 Biomarkers: Potential uses and limitations. Richard Mayeux. J. Amer. Soc. Exp. Neuro Therap. Vol. 1, 182–188, April 2004